Tennessee Oncology, PLLC - Murfreesboro

Clinical research site in Murfreesboro, Tennessee · 1840 MEDICAL CENTER PKWY, SUITE 300, MURFREESBORO, TN 37129-2564 · (615) 848-0488

Part of Tennessee Oncology

As of July 2026, 5 paid clinical trials are recruiting at Tennessee Oncology, PLLC - Murfreesboro in Murfreesboro, Tennessee. Active studies at this site cover conditions such as Advanced Non-Small Cell Lung Cancer, Advanced/Metastatic Urothelial Cancer and Cancer of the Prostate. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Tennessee Oncology, PLLC - Murfreesboro (5)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for Urothelial Cancer

74 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Advanced Non-Small Cell Lung Cancer

186 locations incl. Bullhead City

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for Carcinoma, Renal Cell

109 locations incl. Phoenix

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

133 locations incl. Alabaster

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

More research sites in Murfreesboro

International Clinical Research Tennessee LCC (2 trials)
AARA Clinical Research - Murfreesboro Medical Clinic (2 trials)
Clinical Trial Site (1 trial)
Comprehensive Pain & Neurology Center (1 trial)
International Clinical Research (IC Research) - Murfreesboro (1 trial)
International Clinical Research - Tennesee, LLC (1 trial)
International Clinical Research - Tennessee (IC Research) (1 trial)
International Clinical Research - Tennessee LLC (1 trial)
Local Institution - 0067 (1 trial)
Local Institution - 007-928-F (1 trial)

Explore more

Paid clinical trials in Murfreesboro, TN · Tennessee clinical trials